Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
Yilmaz
S
S
Transplantation Laboratory, University of Helsinki, Finland.
Taskinen
E
E
Häyry
P
P
Isoniemi
H
H
D001706:Biopsy; D002908:Chronic Disease; D016572:Cyclosporine / Q000009:adverse effects; D003937:Diagnosis, Differential; D006084:Graft Rejection / Q000473:pathology*; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology* / Q000502:physiology; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology / Q000502:physiology
D007166:Immunosuppressive Agents; D016572:Cyclosporine